Bank Julius Baer & Co. Ltd, Zurich Cure Vac N.V. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 May 16, 2024	BUY	$3.96 - $6.41 $3,659 - $5,922	924 New	924 $3,000
Q4 2023 Feb 02, 2024	BUY	$3.96 - $6.41 $3 - $6	1 Added 0.11%	924 $4,000
Q3 2023 Nov 13, 2023	SELL	$6.5 - $10.77 $104 - $172	-16 Reduced 1.7%	923 $6,000
Q2 2023 Jul 20, 2023	BUY	$6.69 - $12.25 $66 - $122	10 Added 1.08%	939 $10,000
Q1 2023 May 11, 2023	SELL	$6.38 - $12.5 $140 - $275	-22 Reduced 2.31%	929 $6,000
Q4 2022 Jan 24, 2023	SELL	$5.75 - $8.5 $701 - $1,037	-122 Reduced 11.37%	951 $6,000
Q3 2022 Nov 04, 2022	BUY	$7.48 - $15.24 $815 - $1,661	109 Added 11.31%	1,073 $8,000
Q2 2022 Jul 22, 2022	BUY	$13.18 - $19.41 $738 - $1,086	56 Added 6.17%	964 $13,000
Q1 2022 May 09, 2022	SELL	$14.73 - $35.25 $33,481 - $80,123	-2,273 Reduced 71.46%	908 $18,000
Q4 2021 Feb 15, 2022	BUY	$33.72 - $48.22 $30,044 - $42,964	891 Added 38.91%	3,181 $109,000
Q3 2021 Nov 12, 2021	SELL	$49.26 - $74.5 $21,920 - $33,152	-445 Reduced 16.27%	2,290 $125,000
Q2 2021 Jul 23, 2021	SELL	$56.91 - $127.53 $42,967 - $96,285	-755 Reduced 21.63%	2,735 $201,000
Q1 2021 May 10, 2021	SELL	$79.79 - $126.29 $8,936 - $14,144	-112 Reduced 3.11%	3,490 $319,000
Q4 2020 Feb 24, 2021	BUY	$46.76 - $136.27 $9,445 - $27,526	202 Added 5.94%	3,602 $292,000
Q3 2020 Nov 10, 2020	BUY	$43.8 - $77.2 $148,920 - $262,480	3,400 New	3,400 $158,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.